As diabetes becomes a global problem, buoyed by increasing rates of obesity and the increasing prevalence of a sedentary lifestyle, the onus for treatment seems to shift away from the most severe sufferers: type 1 diabetics. However, a new study conducted by experts at the Jackson Laboratory, Bar Harbour, may have discovered a crucial element in the mystery surrounding type 1.
The team of scientists, headed by a Dr. Serreze, may have found a way to fix diabetes-causing cells in laboratory mice at a very early stage. The trials could possibly lead to a method of preventing the disease before it has the slightest chance to develop.
Type 1 currently affects an estimated 10% of diabetes sufferers, and is generally treated with a strict regime of insulin. Long-term effects of type 1 can be extremely severe, and include heart disease, stroke, blindness and organ damage.
The 10-year research program conducted at the Jackson Laboratory is set to continue for a guaranteed four further years due to a boost of over a million dollars from a government grant. The study is based around the antigen-presenting cells that lead the body’s white blood cells. It is when these malfunction that insulin-producing islet cells are destroyed, causing diabetes.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…